Finoriq research workspace
ATOSSA THERAPEUTICS, INC. (ATOS) SEC Filings & Filing Highlights
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in. Review ATOS SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
- Company
- ATOSSA THERAPEUTICS, INC. (ATOS)
- Ticker
- ATOS
- Market Cap
- $21.7M
- Latest Price
- $2.52
- Industry
- Biotech & Pharma
ATOSSA THERAPEUTICS, INC. (ATOS) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for ATOSSA THERAPEUTICS, INC. (ATOS).
| Event | Form | Date |
|---|---|---|
| The legal opinion and consent of Gibson, Dunn & Crutcher LLP relating to the issuance and sale...On June 10, 2026, Atossa Therapeutics, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with in... | 8-K1.01 | 2026-06-11 |
| Cover page Interactive Data FileCover page Interactive Data File (embedded within the Inline XBRL document) | 8-K9.01 | 2026-05-08 |
| At the Annual Meeting, each of the Company’s director nominees was elected and each of the othe...On May 7, 2026, Atossa Therapeutics, Inc., a Delaware corporation (the “Company”), held its 2026 Annual Meeting of Stockholders (the “Annua... | 8-K5.07 | 2026-05-08 |
| ATOSSA THERAPEUTICS, INC.: Corporate updateOn April 16, 2026, Atossa Therapeutics, Inc. (the “Company”) announced that on April 13, 2026, the Company entered into a Settlement Agreem... | 8-K8.01 | 2026-04-16 |
| Cover page Interactive Data FileCover page Interactive Data File (embedded within the Inline XBRL document) | 8-K9.01 | 2026-03-25 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.